Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis

References

• Tsimberidou A-M, Kantarjian HM, Wen S, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer 2008;113: 1370–1378.
   PubMed Web of Science ®Google Scholar
• Campidelli C, Agostinelli C, Stitson R, et al. Myeloid sarcoma: extramedullary manifestation of myeloid disorders. Am J Clin Pathol 2009;132:426–437.
   PubMed Web of Science ®Google Scholar
• Alexiev BA, Wang W, Ning Y, et al. Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagn Pathol 2007; 2:42.
   PubMed Web of Science ®Google Scholar
• Klco JM, Welch JS, Nguyen TT, et al. State of the art in myeloid sarcoma. Int J Lab Hematol 2011;33:555–565.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
   PubMed Web of Science ®Google Scholar
• Menasce LP, Banerjee SS, Beckett E, et al. Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 1999;34:391–398.
   PubMed Web of Science ®Google Scholar
• Imrie KR, Kovacs MJ, Selby D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med 1995;123:351–353.
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma. Cancer 2002;94:1739–1746.
   PubMed Web of Science ®Google Scholar
• Neiman RS, Barcos M, Berard C, et al. Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 1981;48: 1426–1437.
   PubMed Web of Science ®Google Scholar
• Breccia M, Mandelli F, Petti MC, et al. Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res 2004;28: 1165–1169.
   PubMed Web of Science ®Google Scholar
• Bönig H, Göbel U, Nürnberger W. Bilateral exopthalmus due to retro-orbital chloromas in a boy with t(8;21)-positive acute myeloblastic acute leukemia. Pediatr Hematol Oncol 2002;19:597–600.
   PubMed Web of Science ®Google Scholar
• Sundareshan TS, Augustus M, Yasha TC, et al. Variant complex translocation t(8;15;21) in acute myeloblastic leukemia (M2) associated with bilateral chloroma. Cancer Genet Cytogenet 1992;64:35–37.
   PubMed Web of Science ®Google Scholar
• Chevallier P, Labopin M, Cornelissen J, et al. Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation. Haematologica 2011;96:1391–1394.
   PubMed Web of Science ®Google Scholar
• Montoro J, Tormo M. Myeloid sarcoma. N Engl J Med 2013; 369:2332–2332.
   PubMed Web of Science ®Google Scholar
• Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2006;21:340–350.
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program Research Data (1973–2010), National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2013, based on the November 2012 submission. Available from: www.seer.cancer.gov
   Google Scholar
• Percy C, Fritz A, Jack A, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: WHO; 2000.
   Google Scholar
• Bakst RL, Tallman MS, Douer D, et al. How I treat extramedullary acute myeloid leukemia. Blood 2011;118:3785–3793.
   PubMed Web of Science ®Google Scholar
• Clark WB, Strickland SA, Barrett AJ, et al. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 2010;95: 860–863.
   PubMed Web of Science ®Google Scholar
• Szomor A, Passweg JR, Tichelli A, et al. Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation. Ann Hematol 1997;75:239–241.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Cancer Incidence – Surveillance, Epidemiology, and End Results (SEER) Registries Research Data. Available from: http://seer.cancer.gov/data/metadata.html
   Google Scholar
• Bulas RB, Laine FJ, Das Narla L. Bilateral orbital granulocytic sarcoma (chloroma) preceding the blast phase of acute myelogenous leukemia: CT findings. Pediatr Radiol 1995;25:488–489.
   PubMed Web of Science ®Google Scholar
• Lan T-Y, Lin D-T, Tien H-F, et al. Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematol 2009;122:238–246.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365.
   PubMed Web of Science ®Google Scholar
• Schwyzer R, Sherman GG, Cohn RJ, et al. Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21). Med Pediatr Oncol 1998;31:144–149.
   PubMedGoogle Scholar
• Byrd JC, Dodge RK, Carroll A, et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999;17:3767–3775.
   PubMed Web of Science ®Google Scholar
• Dastugue N, Payen C, Lafage-Pochitaloff M, et al. Prognostic significance of karyotype in de novo adult acute myeloid leukemia. The BGMT group. Leukemia 1995;9:1491–1498.
   PubMed Web of Science ®Google Scholar
• Delaunay J, Vey N, Leblanc T, et al. Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood 2003;102:462–469.
   PubMed Web of Science ®Google Scholar
• Tsimberidou A-M, Kantarjian HM, Estey E, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia 2003;17: 1100–1103.
   PubMed Web of Science ®Google Scholar
• Bakst R, Wolden S, Yahalom J. Radiation therapy for chloroma (granulocytic sarcoma). Int J Radiat Oncol Biol Phys 2012;82: 1816–1822.
   PubMed Web of Science ®Google Scholar
• Antic D, Elezovic I, Milic N, et al. Is there a “gold” standard treatment for patients with isolated myeloid sarcoma? Biomed Pharmacother 2013;67:72–77.
   PubMed Web of Science ®Google Scholar
• Avni B, Koren-Michowitz M. Myeloid sarcoma: current approach and therapeutic options. Ther Adv Hematol 2011;2:309–316.
   PubMedGoogle Scholar
• Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997;15:466–475.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Population Characteristics. Characteristics of the SEER Population Compared with the Total United States Population. Available from: seer.cancer.gov/registries/characteristics.html
   Google Scholar